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Abstract 
Manganese(II) activation of the methionyl aminopeptidases from Escherichia coli (EcMetAP-I) and the 
hyperthermophilic archaeon Pyrococcus furiosus (PfMetAP-II) was investigated. Maximum catalytic activity for 
both enzymes was obtained with 1 equiv of Mn(II), and the dissociation constants (Kd) for the first metal binding 
site were found to be 6 ± 0.5 and 1 ± 0.5 μM for EcMetAP-I and PfMetAP-II, respectively. These Kd values were 
verified by isothermal titration calorimetry (ITC) and found to be 3.0 ± 0.2 and 1.4 ± 0.2 μM for EcMetAP-I 
and PfMetAP-II, respectively. The hydrolysis of MGMM was measured in triplicate between 25 and 85 °C at eight 
substrate concentrations ranging from 2 to 20 mM for PfMetAP-II. Both specific activity and Km values increased 
with increasing temperature. An Arrhenius plot was constructed from the kcat values and was found to be linear 
over the temperature range 25−85 °C. The activation energy for the Mn(II)-loaded PfMetAP-II hydrolysis of 
MGMM was found to be 25.7 kJ/mol while the remaining thermodynamic parameters calculated at 25 °C are 
ΔG⧧ = 50.1 kJ/mol, ΔH⧧ = 23.2 kJ/mol, and ΔS⧧ = −90.2 J·mol-1·K-1. 
 
Methionyl aminopeptidases (MetAP's)1 represent a unique class of proteases that are capable of the hydrolytic 
removal of N-terminal methionine residues from nascent polypeptide chains (1−4). The biosynthesis of all 
eukaryotic proteins present in the cytosol is initiated with methionine, while in prokaryotes, mitochondria, and 
chloroplasts, the initiator residue is an N-formylmethionine group. The N-formyl group is removed from proteins 
in prokaryotes and eukaryotic organelles by a deformylase, leaving a methionine residue at the amino terminus 
(2). Subsequently, the N-terminal methionine is cleaved by MetAP. While the rationale for the removal of the 
initiator methionine remains unclear, several explanations have been proposed (5). Some involve the facilitation 
of further processing after excision of N-terminal groups such as the removal of signal sequences, proteolytic 
cleavage to generate shorter peptides, and the covalent attachment of residues and blocking groups such as 
acetyl and myristoyl groups (4). The structure of the mature N-terminus plays a role in N-directed degradation 
pathways (3, 6) and in targeting to cellular membranes (1−4). MetAP's are therefore one of the key cellular 
enzymes involved in protein maturation. The physiological importance of MetAP activity is underscored by the 
lethality of the deletion of the genes in Escherichia coli, Salmonella typhimurium, and Saccharomyces 
cerevisiae (7−9). For this reason, MetAP's are under intense scrutiny as potential targets for antibacterial and 
antifungal drugs. 
MetAP's are organized into two classes (types I and II) on the basis of the absence or presence of an extra 62 
amino acid sequence (of unknown function) inserted near the catalytic domain. The type I MetAP from E. 
coli (EcMetAP-I) and the type II MetAP's from Homo sapiens (HsMetAP-II) and Pyrococcus furiosus (PfMetAP-II) 
have been crystallographically characterized (10−13). All of these MetAP's have identical catalytic domains that 
contain a bis(μ-carboxylato)(μ-aquo/hydroxo)dicobalt core with an additional carboxylate residue at each metal 
site and a single histidine residue bound to one of the two metal ions (10−13). Each structure also revealed the 
presence of two solvent molecules in the active site, one of which bridges the two Co(II) ions while the second 
acts as a terminal ligand coordinated to the non-histidine-ligated Co(II) ion. In all three structures, both Co(II) 
ions appear to reside in a trigonal-bipyramidal coordination environment (10−13). Since all of the catalytic 
domain residues are completely conserved for both type I and type II MetAP's, all MetAP's likely bind divalent 
metal ions in a similar fashion. This suggestion was recently verified by comparison of the divalent metal binding 
properties of EcMetAP-I and PfMetAP-II (14, 15). 
Until recently, all MetAP's studied had been reported to be Co(II)-dependent metalloproteases (16, 17). While 
the identity of the in vivo metal ion has not been established for any MetAP, Fe(II) and Mn(II) were suggested as 
potential candidates on the basis of whole cell metal analyses for EcMetAP-I (18). Further studies on Co(II) and 
Fe(II) binding to EcMetAP-I and PfMetAP-II led to the proposal that MetAP's function as mononuclear enzymes 
in vitro (14, 15). Structural evidence for a mononuclear Co(II) or Fe(II) active site in MetAP's was recently 
obtained by use of extended X-ray absorption fine structure (EXAFS) (19). The high-affinity or catalytically 
relevant metal binding site was assigned as the histidine-containing side of the active site on the basis of EXAFS 
and 1H NMR data (15). Mn(II) was also shown to activate EcMetAP-I, but no kinetic or structural information has 
been reported. Herein, we report the catalytic and structural properties of the Mn(II)-loaded forms of 
both EcMetAP-I and PfMetAP-II. On the basis of kinetic, thermodynamic, and EXAFS data, Mn(II) is shown to bind 
to both type I and type II MetAP's in a fashion similar to that of Co(II) and Fe(II). Because PfMetAP-II 
and HsMetAP-II are 39% identical while PfMetAP-II and EcMetAP-I are 33% identical, the structural and 
mechanistic data obtained for the Mn(II)-loaded EcMetAP-I and PfMetAP-II can be extrapolated to HsMetAP-II. 
The catalytic and structural similarities and differences between Co(II)- and Mn(II)-loaded MetAP's are also 
discussed. 
Materials and Methods 
Purification of MetAP Enzymes.  
All chemicals used in this study were purchased commercially and were of the highest quality available. 
Recombinant EcMetAP-I was expressed and purified as an apoenzyme, as previously described, from a stock 
culture kindly provided by Drs. Brian W. Matthews and W. Todd Lowther (18, 20). The as purified EcMetAP-I 
exhibited a single band on SDS−PAGE. Protein concentrations were obtained spectrophotometrically at 280 nm 
using an extinction coefficient ε280 of 16445 M-1 cm-1 (18, 20). Apo-EcMetAP-I was washed free of methionine 
using Chelex-treated methionine-free buffer (25 mM Hepes, pH 7.5, 150 mM KCl) and concentrated by 
microfiltration using a Centrocon-10 (Amicon, Beverly, MA) prior to all kinetic assays. Individual aliquots of apo-
EcMetAP-I were routinely stored at −80 °C or in liquid nitrogen until needed. 
PfMetAP-II was purified as previously reported (14). Purified PfMetAP-II exhibited a single band on SDS−PAGE 
with a Mr of 32800. Protein concentrations were estimated from the absorbance at 280 nm using an extinction 
coefficient of 21650 M-1 cm-1. Metal-free PfMetAP-II was prepared by concentrating the as purified PfMetAP-II 
to a volume of ∼5 mL after which EDTA was added to a final concentration of 10 mM. The resulting protein 
solution was dialyzed against 25 mM Hepes buffer (2 L, pH 7.5) containing 10 mM EDTA and 150 mM KCl at 4 °C 
for 2 days with two buffer changes per day. The protein solution was then dialyzed against chelexed (Chelex-100 
column) 25 mM Hepes buffer (2 L, pH 7.5) containing 150 mM KCl for 3 days against two buffer changes per day. 
The resulting PfMetAP-II was inactive and was found to contain no detectable metal ions via inductively coupled 
plasma-atomic emission spectrometry (ICP-AES). This enzyme deemed “apo-PfMetAP-II” was stored at −80 °C. 
Metal Content Measurements.  
EcMetAP-I and PfMetAP-II samples used for metal analysis were typically 30 μM. Apo-EcMetAP-I or apo-
PfMetAP-II samples were incubated under anaerobic conditions with Mn(II) (MnCl2 = 99.999%; Strem Chemicals, 
Newburyport, MA, or Aldrich) for 30 or 90 min, respectively, prior to exhaustive dialysis under anaerobic 
conditions against Chelex-treated buffer as previously reported (15, 18). Metal analyses were performed using 
ICP-AES. 
Enzymatic Assay of MetAP's.  
All enzymatic assays were performed under strict anaerobic conditions in an inert atmosphere glovebox (Coy) 
with a dry bath incubator to maintain the temperature. Catalytic activities were determined with an error of 
±5%. Enzyme activities for both EcMetAP-I and PfMetAP-II were determined in 25 mM Hepes buffer, pH 7.5, 
containing 150 mM KCl with the tri- or tetrapeptide substrates MAS or MGMM, respectively. The amount of 
product formation was determined by high-performance liquid chromatography (HPLC, Shimadzu LC-10A class-
VP5). A typical assay involved the addition of 4 μL of metal-loaded MetAP to a 16 μL substrate−buffer mixture at 
30 °C for 1 min. The reaction was quenched by the addition of 20 μL of 1% trifluoroacetic acid solution (TFA). 
Elution of the product was monitored at 215 nm following separation on a C8 HPLC column (Phenomenex, Luna; 
5 μm, 4.6 × 25 cm), as previously described (15, 18). The kinetic parameters v (velocity) and Km (Michaelis 
constant) were determined in triplicate. Enzyme activities are expressed as units per milligram, where one unit is 
defined as the amount of enzyme that releases 1 μmol of product in 1 min at 30 °C. The metal binding titration 
and temperature dependence reactions were carried out using the same conditions as determined for the 
kinetic constants. 
Isothermal Titration Calorimetry.  
Isothermal titration calorimetry (ITC) measurements were carried out on a MicroCal OMEGA ultrasensitive 
titration calorimeter. The titrant (MnCl2 = 99.999%; Strem Chemicals, Newburyport, MA, or Aldrich) and sample 
solutions (apo-EcMetAP-I or apo-PfMetAP-II) were prepared in chelexed 25 mM Hepes buffer at pH 7.5 
containing 150 mM KCl. Stock buffer solutions were thoroughly degassed before each titration. The enzyme 
solution (70 μM) was placed in the calorimeter cell and stirred at 200 rpm to ensure rapid mixing. Typically, 3 μL 
of titrant was delivered over 7.6 s with a 5 min interval between injections to allow for complete equilibration. 
Each titration was continued until 4.5−6 equiv of Mn(II) had been added to ensure that no additional complexes 
were formed in excess titrant. A background titration, consisting of the identical titrant solution but only the 
buffer solution in the sample cell, was subtracted from each experimental titration to account for heat of 
dilution. The data were analyzed with a two-site binding model by the Windows-based Origin software package 
supplied by MicroCal. 
X-ray Absorption Spectroscopy of EcMetAP-I.  
EXAFS samples of EcMetAP-I (1 mM) with 1 or 2 equiv of added Mn(II) (i.e., [Mn(II)_(EcMetAP-I)] and 
[Mn(II)Mn(II)(EcMetAP-I)]) were prepared in chelexed 25 mM Hepes buffer at pH 7.5 containing 150 mM KCl 
with 5% glycerol. For Mn(II)-loaded EcMetAP-I, EXAFS samples were frozen in polycarbonate cuvettes, 24 × 3 × 1 
mm, with a 0.025 mm Mylar window covering one 24 × 3 mm face. XAS data were collected at the Stanford 
Synchrotron Radiation Laboratory (SSRL) with the SPEAR storage ring operating at 3.0 GeV (Table 1). The edge 
regions for multiple scans obtained on the same sample were compared to ensure that the sample was not 
damaged by exposure to X-ray radiation. EXAFS analysis was performed using EXAFSPAK software (www-
ssrl.slac.stanford.edu/exafspak.html) according to standard procedures (21). Multiple-scattering analysis was 
performed as described previously (19). Both single- and multiple-scattering paths of 4.5 Å from the Mn atom 
were used to identify and quantify imidazole coordination due to histidine. Multiple-scattering models, 
calculated using FEFF v7 (23), were based on hexaimidazole manganese(II) chloride tetrahydrate (24). Possible 
coordination numbers of histidyl imidazole ligands were chosen from fits that yielded chemically and physically 
reasonable Debye−Waller factors for the outer-shell atoms, since goodness-of-fit values (f ‘) were relatively 
insensitive to these coordination numbers. 
 
Table 1:  X-ray Absorption Spectroscopic Data Collection 
  Mn EXAFS 
SR facility SSRL 
beamline 7-3 
current in storage ring, mA 80−100 
monochromator crystal Si[220] 
detection method fluorescence 
detector type solid state arraya 
scan length, min 28 
scans in average 16 
temperature, K 10 
energy standard Mn foil, first inflection 
energy calibration, eV 6539 
E0, eV 6545 
preedge background   
energy range, eV 6215−6500 
Gaussian center, eV 5898 
width, eV 800 
spline background   
energy range, eV 6545−6730 (4) 
(polynomial order) 6730−6915 (4) 
a The 13-element Ge solid-state X-ray fluorescence detector at SSRL is provided by the NIH Biotechnology 
Research Resource. 
 
Results 
Time Dependence of Mn(II) Binding and Mn(II) Content of EcMetAP-I and PfMetAP-II.  
The time required to fully activate either EcMetAP-I or PfMetAP-II with Mn(II) ions was measured (Figure 1). 
For EcMetAP-I, no change in the specific activity was observed even with incubation times as short as 10 min. 
However, for PfMetAP-II, fully active enzyme was not obtained until after 90 min had passed. Therefore, all 
kinetic and metal binding measurements for PfMetAP-I were made after a 90 min incubation period. 
Interestingly, Fe(II) and Co(II) activate PfMetAP-II in 10 min, similar to EcMetAP-I. The number of tightly bound 
Mn(II) ions was determined for EcMetAP-I and PfMetAP-II by ICP-AES analysis. MetAP samples (30 μM), to which 
2−30 equiv of Mn(II) was added, were dialyzed extensively for 3 h at 4 °C against metal-free Hepes buffer. Upon 
ICP-AES analysis 1.3 and 1.5 ± 0.1 equiv of manganese was found coordinated to EcMetAP-I and PfMetAP-II, 
respectively. These data suggest that one Mn(II) ion is tightly bound to both EcMetAP-I and PfMetAP-II at these 
enzyme concentrations, while the second metal ion is partially labile on the time scale of the buffer exchange (3 
h, 4 °C). 
 
Figure 1 Plot of specific activity (units/mg) vs time. The solid bars represent activities obtained for Mn(II)-
loaded EcMetAP-I, and the shaded bars are activity levels observed for Mn(II)-loaded PfMetAP-II. All activity 
measurements were performed at 30 °C, and all stock solutions were prepared anaerobically in 25 mM Hepes 
buffer at pH 7.5 containing 150 mM KCl. Each point represents the mean of three independent measurements. 
 
Determination of the Km Values for MAS and MGMM.  
The strength of MAS and MGMM binding to the active site of Mn(II)-loaded EcMetAP-I and PfMetAP-II was 
determined (Table 2). The initial rates of hydrolysis of MAS or MGMM by Mn(II)-loaded EcMetAP-I and PfMetAP-
II were monitored as a function of AS or GMM concentration, respectively, in 25 mM Hepes buffer, pH 7.5, and 
150 mM KCl. Triplicate activity assay determinations at six concentrations of MAS or MGMM (0−9 mM) were 
made and the results plotted as 1/v vs 1/[S]. From fits of these data, the Michaelis constant (Km) for MAS and 
MGMM binding to Mn(II)-loaded EcMetAP-I and PfMetAP-II was determined (Table 2). For Mn(II)-
loaded EcMetAP-I, no catalytic turnover was observed in the presence of MAS even at substrate concentrations 
of 20 mM while Mn(II)-loaded PfMetAP-II bound MAS weakly (Km = 5.7 mM). Similarly, kcat values were 
determined for Mn(II)-loaded PfMetAP-II toward both substrates and EcMetAP-I toward MGMM. A 16-fold 
decrease in kcat was observed for Mn(II)-loaded PfMetAP-II toward MAS vs MGMM. This decrease in kcat results 
in a decrease in the catalytic efficiency (kcat/Km) of over 60-fold. Interestingly, at 30 °C Mn(II)-loaded EcMetAP-I 
exhibits a turnover rate that is more than 13 times faster than Mn(II)-loaded PfMetAP-II toward MGMM. Since 
the Km values are similar for the two enzymes toward MGMM, Mn(II)-loaded EcMetAP-I is a better catalyst by 
16-fold. On the other hand, at 85 °C, the optimum temperature for catalytic activity for Mn(II)-loaded PfMetAP-
II, the kcat value increases 5-fold to164 s-1, but the Km value also increases over 6-fold to 10.3 mM, resulting in a 
catalytic efficiency of 15900 M-1 s-1, a 1.3-fold decrease. 
Table 2:  Kinetic Constants for Mn(II)-Loaded EcMetAP-I and PfMetAP-II for Various Substrates at 30 °C and pH 
7.5 
enzyme kinetic constants MGMM MAS 
Mn-EcMetAP-I Km (mM) 1.3 ± 0.2 NRa 
  kcat (s-1) 4.6   
  kcat/Km (M-1 s-1) 3500   
  Vmax (nmol min-1) 12.9 ± 0.4   
  SA (units/mg) 13 ± 2   
Mn-PfMetAP-II Km (mM) 1.6 ± 0.2 5.7 ± 0.2 
  kcat (s-1) 32 ± 4 1.96 
  kcat/Km (M-1 s-1) 20800 344 
  Vmax (nmol min-1) 155 ± 5 2.4 + 0.3 
  SA (units/mg) 59 ± 5 3.6 ± 0.8 
a No reaction was detected. 
Activity as a Function of Manganese(II) Concentration.  
The extent of hydrolytic activity exhibited by EcMetAP-I and PfMetAP-II was determined as a function of Mn(II) 
concentration. Apo-EcMetAP-I and apo-PfMetAP-II (both at 8.3 μM) were incubated with varying amounts of 
Mn(II), and the level of catalytic activity was determined (Figure 2). Upon the addition of Mn(II) to apo-EcMetAP-
I or apo-PfMetAP-II under anaerobic conditions, the specific activity increased as a function of metal ion 
concentration up to approximately 2 equiv of Mn(II) for both EcMetAP-I and PfMetAP-II (Figure 2, inset). Further 
additions of up to 5 equiv of Mn(II) to either enzyme had little or no effect on the observed enzymatic activity. 
Interestingly, upon the addition of Mn(II) up to >830 μM (∼100 equiv) the activity level of both enzymes 
remained constant and continued to remain constant even up to 400 equiv of added Mn(II) (Figure 2). 
 
Figure 2 Plot of specific activity vs Mn(II) concentration (inset:  expanded view of the 0−10 equiv region). All 
activity measurements were performed at 30 °C, and all stock solutions were prepared anaerobically in 25 mM 
Hepes buffer at pH 7.5 containing 150 mM KCl. Each point represents the mean of three independent 
measurements. 
 
The activity titration data for Mn(II) binding to EcMetAP-I and PfMetAP-II (Figure 3) were fit to the equation (24): 
𝑟𝑟 = 𝑝𝑝𝐶𝐶𝑠𝑠/(𝐾𝐾𝑑𝑑 + 𝐶𝐶𝑠𝑠) (1) 
where p is the number of sites for which interaction with M(II) is governed by the intrinsic dissociation 
constant Kd and r is the binding function which was calculated as previously described (14). A value for the 
dissociation constants (Kd) was obtained by fitting these data via an iterative process that allowed 
both Kd and p to vary (Figure 3). The best fits obtained provided p values of 1 for both EcMetAP-I and PfMetAP-II 
with Kd values of 6 ± 0.5 and 1 ± 0.5 μM for Mn(II)-loaded EcMetAP-I and PfMetAP-II, respectively. Attempts to 
fit these data with a p value of 2 provided no improvements in the overall goodness of the fit. 
 
Figure 3 Plot of binding function, r, vs Cs (the concentration of free metal ions in solution) for Mn(II) titration 
into PfMetAP-II (·) and EcMetAP-I (▪). The solid lines represent fits of the activity data to eq 1. Enzyme 
concentrations were 8.3 μM, and the measurements were made at 30 °C in 25 mM Hepes buffer, pH 7.5, and 
150 mM KCl. 
 
Isothermal Titration Calorimetry.  
Isothermal titration calorimetry (ITC) measurements were carried out on a MicroCal OMEGA ultrasensitive 
titration calorimeter at 20 ± 0.2 °C for EcMetAP-I and 30 ± 0.2 °C for PfMetAP-II (Figures 4A and 5A). Association 
constants (Kb) were obtained by fitting these data, after subtraction of the background heat of dilution, via an 
iterative process using the Origin software package. This software package uses a nonlinear least-squares 
algorithm which allows the concentrations of the titrant and the sample to be fit to the heat flow per injection 
to an equilibrium binding equation for two sets of noninteracting sites. The Kb value, the enzyme−metal 
stoichiometry (n), and the change in enthalpy (ΔH°) were allowed to vary during the fitting process. The best fits 
obtained for both EcMetAP-I and PfMetAP-II provided an overall n value of 3 for three noninteracting sites 
(Figures 4B and 5B). Attempts to fit these data with n values of 1 or 2 provided poor fits as did fits in which 
the n value was 3 but the binding process was considered cooperative. For EcMetAP-I, a Kd value of 3.0 ± 0.2 μM 
was observed, and two Kd values of 4400 ± 300 μM were also obtained. On the other hand, a Kd value of 1.4 ± 
0.2 μM was obtained for PfMetAP-II, and two Kd values of 500 ± 50 μM were also obtained. These data 
correspond to individual binding events of three Mn(II) ions to the EcMetAP-I and PfMetAP-II enzymes. 
 
Figure 4 ITC titration of a 70 μM solution of EcMetAP-I with a 5 mM Mn(II) solution at 20 °C in 25 mM Hepes 
buffer, pH 7.5, and 150 mM KCl. 
 
 
Figure 5 ITC titration of a 70 μM solution of PfMetAP-II with a 5 mM Mn(II) solution at 30 °C in 25 mM Hepes 
buffer, pH 7.5, and 150 mM KCl. 
 
Temperature Dependence of the Hydrolysis of MGMM by Mn(II)-Loaded PfMetAP-II.  
Mn(II)-loaded PfMetAP-II was found to have optimal catalytic activity toward MGMM at 85 °C in 25 mM Hepes, 
pH 7.5, and 150 mM KCl buffer. Therefore, hydrolysis of MGMM was measured in triplicate between 25 and 85 
°C at eight substrate concentrations ranging from 2 to 20 mM. From these data, Km values were derived by 
fitting the experimental data to the Michaelis−Menten equation at each temperature studied (Figure 6B). The 
calculated specific activity values were plotted as a function of temperature between 25 and 85 °C (Figure 6A). 
The Km and specific activity values for MGMM hydrolysis catalyzed by Mn(II)-loaded PfMetAP-II were found to 
increase with increasing temperature. PfMetAP-II was stable at 85 °C for approximately 30 min before any loss 
in the enzymatic activity was detected. However, any loss in enzymatic activity was fully reversible, determined 
by Vmax, for temperatures up to 70 °C. These data are very unusual since most enzymes undergo some 
denaturation at temperatures above 50 °C resulting in a decrease in Vmax (25). 
 
Figure 6 (A) Plot of specific activity (units/mg) of Mn(II)-loaded (·) PfMetAP-II vs temperature between 25 and 85 
°C. Each data point is the sum of three activity measurements at pH 7.5 in 25 mM Hepes buffer and 150 mM KCl 
at substrate concentrations ranging from 2 to 20 mM. (B) Km vs temperature (°C). 
 
Since the enzyme concentration was not altered over the course of the experiment, an Arrhenius plot was 
constructed by plotting ln kcat vs 1/T (Figure 7). A linear plot was obtained, indicating that the rate-limiting step 
does not change as the temperature is increased (25). From the slope of the line the activation energy, Ea, for 
temperatures between 296 and 358 K was calculated to be 25.7 kJ/mol for Mn(II)-loaded PfMetAP-II. Since the 
slope of an Arrhenius plot is equal to −Ea1/R, where R = 8.3145 J·K-1·mol-1, other thermodynamic parameters 
were calculated by the relations ΔG⧧ = −RT ln(kcath/kBT), ΔH⧧ = Ea − RT, and ΔS⧧ = (ΔH⧧ − ΔG⧧)/T, where kB, h, 
and R are the Boltzmann, Planck, and gas constants, respectively, and were found to be ΔG⧧ = 50.1 kJ/mol, ΔH⧧ = 
23.2 kJ/mol, and ΔS⧧ = −90.2 J·mol-1·K-1. 
 
Figure 7 Arrhenius plot of ln kcat vs 1/T for Mn(II)-loaded (·) PfMetAP-II. The solid line is a direct fit to the 
Arrhenius equation. 
 
X-ray Absorption Spectroscopy of EcMetAP-I.  
Manganese K-edge X-ray absorption (XAS) spectra were acquired on 1 mM samples of EcMetAP-I with 1 or 2 
equiv of added Mn(II) (i.e., [Mn(II)_(EcMetAP-I)] and [Mn(II)Mn(II)(EcMetAP-I)]). For [Mn(II)Mn(II)(EcMetAP-I)], 
the EXAFS data reveal an average of both metal ion environments. The 1s → 3d preedge transitions for each 
sample occur at 6540 eV (Figure 8). Since 1s → 3d preedge transitions are Laporte forbidden in centrosymmetric 
environments (e.g., octahedral but not tetrahedral), the intensity of the 1s → 3d preedge transition is inversely 
proportional to coordination number. The intensities of the observed transitions for all three samples are 
consistent with, on average, five- or six-coordinate Mn(II) sites. 
 
Figure 8 X-ray absorption K-edge spectra for EcMetAP-I:  [Mn(II)_(EcMetAP-I)] (solid) and 
[Mn(II)Mn(II)(EcMetAP-I)] (dotted). In the inset, the preedge 1s → 3d transition is expanded. 
 
Fourier transforms (FTs) of the EXAFS data for both samples are dominated by a peak at ca. 2.1 Å (Figure 9, 
bottom). Excellent single-shell fits of EXAFS spectra for both [Mn(II)_(EcMetAP-I)] and [Mn(II)Mn(II)(EcMetAP-I)] 
were obtained with 5 or 6 N/O scatterers at 2.15 Å (fits 1−3 and 6−8; Table 3). Attempts to include a Mn−Mn 
interaction in the 2.4−4.0 Å range in the curve fitting parameters were unsuccessful. Inclusion of multiple-
scattering contributions from the outer-shell atoms of a histidine imidazole ring resulted in reasonable 
Debye−Waller factors and a slight reduction in the goodness-of-fit value (f ‘) for [Mn(II)_ (EcMetAP-I)] (cf. fits 2 
and 4; Table 3). If a second histidine imidazole ring was included in fits for [Mn(II)_(EcMetAP-I)], the 
Debye−Waller factor values are significantly higher (fit 5; Table 3). For [Mn(II)Mn(II)(EcMetAP-I)], inclusion of a 
single outer-shell histidine scatterer resulted in a Debye−Waller factor that is similar in magnitude to those 
obtained with two outer-shell histidine scatterers for [Mn(II)_ (EcMetAP-I)] (cf. fits 4, 5, and 9; Table 3). The 
Debye−Waller factor values are significantly higher for [Mn(II)Mn(II)(EcMetAP-I)] than [Mn(II)_(EcMetAP-I)], 
consistent with the first Mn(II) ion binding to the histidine-containing site. 
 
Figure 9 k3-weighted Mn EXAFS (top) and Fourier transforms (bottom, over k = 2−11.5 Å-1) for 
[Mn(II)_(EcMetAP)] (a; solid) and the calculated spectra for Mn−O5(imid) (dotted; fit 4, Table 2) and for 
[Mn(II)Mn(II)(EcMetAP-I)] (b; solid) and the calculated spectra for Mn−O6 (dotted; fit 7, Table 2). 
 
 
Figure 10 Drawing of the proposed active site of Mn(II)-loaded PfMetAP-II or EcMetAP-I compared to the X-ray 
crystallographically characterized dicobalt form of PfMetAP-II and the dimanganese form of aminopeptidase P 
from E. coli. 
 
Table 3:  Curve Fitting Results for Mn-Loaded EcMetAP-I EXAFSa 
sample fit shell Ras (Å) σas2 (Å2) ΔE0 (eV) f ‘ b 
[Mn(II)_(EcMetAP-I)] 1 Mn−O5 2.15 0.0044 −1.32 0.120 
MM20A (2−11.5 Å-1) 2 Mn−O6 2.15 0.0058 −1.68 0.114 
Δk3χ = 12.26 3 Mn−O7 2.15 0.0071 −1.94 0.113 
  4 Mn−(O,N)6 2.15 0.0058 −1.89 0.111 
    Mn−Cimid 2.91 0.0036     
    Mn−Cimid [3.01] [0.0037]     
    Mn−Nimid [3.98] [0.0049]     
    Mn−Cimid [4.03] [0.0049]     
  5 Mn−(O,N)6 2.15 0.0058 −1.95 0.110 
    Mn−(Cimid)2 2.93 0.0096     
    Mn−(Cimid)2 [3.02] [0.0100]     
    Mn−(Nimid)2 [4.00] [0.0132]     
    Mn−(Cimid)2 [4.06] [0.0132]     
[Mn(II)Mn(II)(EcMetAP-I)] 6 Mn−O5 2.16 0.0047 −1.51 0.082 
MM22A (2−11.5 Å-1) 7 Mn−O6 2.16 0.0062 −1.61 0.075 
Δk3χ = 11.82 8 Mn−O7 2.16 0.0076 −1.64 0.075 
  9 Mn−(O,N)6 2.16 0.0062 −1.57 0.071 
    Mn−Cimid 2.97 0.0095     
    Mn−Cimid [3.07] [0.0099]     
    Mn−Nimid [4.05] [0.0131]     
    Mn−Cimid [4.11] [0.0131]     
a Group is the chemical unit defined for the multiple scattering calculation. Ns is the number of scatterers (or 
groups) per metal. Ras is the metal-scatterer distance. σas2 is a mean square deviation in Ras. ΔE0 is the shift 
in E0 for the theoretical scattering functions. Numbers in brackets were constrained either to be a multiple of 
the above value (σas2) or to maintain a constant difference from the above value (Ras, ΔE0).b f ‘ is defined as 
follows (chi-squared):  f ‘ = {?i[k3(χiobs − χicalc)]2/N?? 1/2}/[(k3χobs)max − (k3χobs)min]. 
 
Discussion 
Until recently, all MetAP's studied have been reported to be Co(II)-dependent metalloproteases (16, 17). This 
conclusion was arrived at from the reproducible observations that MetAP's show high activity in the presence of 
Co(II) when compared to the activity levels of other divalent metal ions such as Zn(II), Cu(II), or Ni(II). However, 
in all in vitro studies to date, Co(II) concentrations were artificially inflated to the millimolar range during 
purification. Walker and Bradshaw were the first to suggest that MetAP's could be activated by Zn(II) ions on the 
basis of activity measurements made on the type I MetAP from S. cerevisiae (26); however, EcMetAP-I and more 
recently PfMetAP-I and HsMetAP-II were shown to be inactive in the presence of Zn(II), but each of these 
enzymes is fully active in the presence of 1 equiv of Co(II) while EcMetAP-I and PfMetAP-II are equally as active 
in the presence of 1 equiv of Fe(II) (18). On the other hand, EcMetAP-I was found to retain 30% of the observed 
Co(II) activity in the presence of excess Mn(II) (18). Iron, manganese, and zinc, unlike cobalt, are abundant in 
nature and have many known biological roles (27). The question of what type and how many divalent metal ions 
are required to activate MetAP's is of particular importance since MetAP's are currently under heavy 
investigation as antiangiogenesis targets for anticancer drugs. To design and synthesize small molecule drug 
candidates with nanomolar or picomolar binding constants to MetAP's, the number, geometry, and type of in 
vivo metal ions must be elucidated. 
The evidence suggesting that a single Fe(II) ion is required to activate all MetAP's is growing but has yet to be 
unequivocally proven. Since Mn(II) ions can also activate MetAP's, we have investigated the enzymatic activity of 
Mn(II)-loaded EcMetAP-I and PfMetAP-II. Activity measurements as a function of added Mn(II) show that 
both EcMetAP-I and PfMetAP-II are maximally stimulated upon the addition of 2 equiv of metal ion. The addition 
of up to 400 equiv of Mn(II) did not significantly change the observed catalytic activity levels. In addition, ICP-
AES analyses of 30 μM Mn(II)-loaded EcMetAP-I and PfMetAP-II samples that had been extensively dialyzed 
against metal-free buffer routinely indicated that 1.3 and 1.5 equiv of divalent metal ions are tightly bound per 
enzyme molecule to EcMetAP-I and PfMetAP-II, respectively. These data suggest that at least one Mn(II) ion is 
tightly bound to both enzymes while a second is more weakly bound and likely in equilibrium between a metal-
bound and unbound form at these enzyme concentrations (∼8 μM). Moreover, these data indicate that the 
monometal form of EcMetAP-I and PfMetAP-II is catalytically competent. To determine if a dinuclear site is 
formed at an enzyme concentration of ∼8 μM, the metal binding constants for both metal binding events were 
determined. 
Fits of the titration data obtained for both EcMetAP-I and PfMetAP-II with Mn(II) ions provided dissociation 
constants (Kd) for the first metal binding site of 6 and 1 μM, respectively. Since only one metal ion is bound to 
the enzyme active site, these Kd values correspond to the microscopic binding constants for the binding of a 
single metal ion to EcMetAP-I and PfMetAP-II. Confirmation of these Kd values was obtained from isothermal 
titration calorimetry (ITC), which provided Kd values of 4.4 and 1.3 μM for Mn(II) binding to EcMetAP-I 
and PfMetAP-II, respectively. Further, the ITC data indicated that two additional Mn(II) ions can bind to 
both EcMetAP-I and PfMetAP-II with Kd values of 4400 and 500 μM, respectively. A second Co(II) ion has been 
shown to bind to EcMetAP-I and PfMetAP-II with Kd values of 2500 and 500 μM, respectively. Moreover, a third 
Co(II) ion binding site was identified in the X-ray crystal structure of EcMetAP-I (11). On the basis of these data 
and those presented herein, only one Mn(II) ion is tightly bound to either EcMetAP-I or PfMetAP-II, and thus 
only one Mn(II) ion is needed to activate either enzyme. The fact that the catalytic activity does not plateau until 
more than 2 equiv of Mn(II) are added is because the Kd values for the first metal binding event is on the order 
of the enzyme concentration used in the experiment. Our data also suggest that the putative second metal ion 
in the active site of MetAP's and the third metal binding site have similar metal binding affinities. 
The Kd values obtained for Mn(II) binding to EcMetAP-I and PfMetAP-II are somewhat weaker than those 
observed for Co(II) or Fe(II) EcMetAP-I and PfMetAP-II. For EcMetAP-I and PfMetAP-II, the Kd values for Co(II) 
binding were 300 and 50 nM while those for Fe(II) binding were 200 and 20 nM, respectively (15). The Kd values 
observed for Mn(II) binding to either EcMetAP-I or PfMetAP-II are approximately a factor of 5 weaker than Co(II) 
or Fe(II) binding to either enzyme. The observed Kd values for the first Mn(II) binding event to either EcMetAP-I 
or PfMetAP-II are also 10−100 times larger than the reported Kd values for several other hydrolytic enzymes that 
contain carboxylate-rich active sites. For example, the Kd values for the first metal binding site of the 
aminopeptidase from Aeromonas proteolytica is 1 nM (28), and the β-lactamase from Bacillus cereus has a 
divalent metal ion Kd value of 620 nM (29). On the other hand, the observed Kd values for Mn(II) binding 
to EcMetAP-I or PfMetAP-II are similar in magnitude to the Kd value reported for the Mn(II)-dependent clostridial 
aminopeptidase P (AMPP) of 7 μM, which has active site ligands identical to those of MetAP's (30). 
Since PfMetAP-II is stable at 75 °C for 1 h, PfMetAP-II provides the unique opportunity to determine the 
activation parameters of the ES⧧ complex over a wide temperature range. Construction of an Arrhenius plot 
from the temperature dependence of Mn(II)-loaded PfMetAP-II activity indicates that the rate-limiting step does 
not change as a function of temperature and is product release (25). This finding is similar to that obtained for 
Co(II)- and Fe(II)-loaded PfMetAP-II (14). The activation energy (Ea) for the activated ES⧧ complex is 25.7 kJ/mol, 
which is nearly double the value obtained for either Co(II)- and Fe(II)-loaded PfMetAP-II (14). The enthalpy of 
activation calculated over the temperature range 25−85 °C is 23.2 kJ/mol while the entropy of activation was 
found to be −90.2 J·mol-1·K-1 at 25 °C. The positive enthalpy is indicative of a conformation change upon 
substrate binding, likely due to the energy of bond formation and breaking during nucleophilic attack on the 
scissile carbonyl carbon of the substrate. On the other hand, the large negative entropy value suggests that 
some of the molecular motions are lost upon ES⧧ complex formation possibly due to hydrogen bond formation 
between catalytically important amino acids and the substrate. All of these factors contribute to the large 
positive free energy of activation of 50.1 kJ/mol. Interestingly, the observed specific activity of Mn(II)-
loaded PfMetAP-II increases from ∼60 to 300 units/mg between 25 and 85 °C. The specific activity observed for 
Mn(II)-loaded PfMetAP-II at 85 °C is roughly equal to the specific activity of Co(II)- and Fe(II)-loaded PfMetAP-II 
at 25 °C but is still ∼3 times lower than the activity levels obtained at 85 °C. However, the Km value for Mn(II)-
loaded PfMetAP-II also increases to over 10 mM at 85 °C so the catalytic efficiency of Mn(II)-loaded PfMetAP-II 
does not change significantly over this temperature range. On the basis of these data, Fe(II)-loaded PfMetAP-II is 
a much better catalyst at the optimum growth temperature of P. furiosus (85 °C) than either Co(II)- or Mn(II)-
loaded PfMetAP-II (14). These data further suggest that Fe(II) is the physiologically relevant metal ion. 
Since Mn(II)-loaded EcMetAP-I and PfMetAP-II are colorless and no X-ray structural data have been reported, 
the structural aspects of these catalytically competent MetAP enzymes are unknown. Therefore, extended X-ray 
absorption fine structure (EXAFS) data were recorded on [Mn(II)_ (EcMetAP-I)] and [Mn(II)Mn(II)(EcMetAP-I)] 
and provide the first structural glimpse of the Mn(II) active sites of EcMetAP-I. The EXAFS data are consistent 
with the X-ray crystal structure of Co(II)-loaded EcMetAP-I, which indicates that the histidine-ligated Co(II) ion 
resides in a distorted trigonal-bipyramidal coordination environment made up of oxygen or nitrogen donor 
ligands while the second Co(II) ion is also trigonal bipyramidal (12, 31). The average bond distances obtained by 
EXAFS for both EcMetAP-I samples are in good agreement with the crystallographically determined bond lengths 
for [Co(II)Co(II)(EcMetAP-I)] of 2.04 Å (12). Additionally, it was recently reported, on the basis of 1H NMR data, 
that upon the addition of Co(II) to EcMetAP-I, the first Co(II) is bound to the lone histidine residue in the active 
site (15). This is consistent with the suggestion of a single histidine ligand at the active site, based on 
crystallographic analyses. The Debye−Waller factor values for the Mn−histidine interaction are significantly 
higher for [Mn(II)Mn(II)(EcMetAP-I)] than for [Mn(II)_ (EcMetAP-I)], suggesting that the first Mn atom is located 
in the histidine-ligated site. Furthermore, the EXAFS data do not detect a Mn−Mn interaction similar to data 
obtained for [Co(II)Co(II)(EcMetAP-I)] and [Fe(II)Fe(II)(EcMetAP-I)] (19). These data indicate that a dinuclear 
Mn(II) site does not exist in EcMetAP-I, as seen in the published X-ray crystal structures for all Co(II)-loaded 
MetAP's (11, 12). The lack of a M−M FT peak in the second shell of [Mn(II)Mn(II)(EcMetAP-I)] is consistent with a 
single Mn(II) ion being capable of activating MetAP's and is also in line with the metal binding constants 
reported herein. 
Biological and Mechanistic Implications. According to the recently proposed mechanism for the aminopeptidase 
from A. proteolytica (AAP), substrate binding to the hydrophobic pocket adjacent to the dinuclear active site is 
the first step in catalysis (32). Since a hydrophobic pocket is also adjacent to the metallo active site in all 
MetAP's, the first step in catalysis for MetAP's is likely similar to AAP. When substrate (MGMM) binds to MetAP, 
the carbonyl oxygen of the N-terminal methionine must be activated, probably by binding to the active site 
metal ion (31). Once carbonyl activation occurs, the nucleophilic hydroxide must be oriented correctly for attack 
on the scissile carbonyl carbon. For Zn(II)-loaded EcMetAP-I and PfMetAP-II, the correct positioning of the 
scissile carbonyl carbon must not occur for catalytic turnover since each of these enzymes is inactive in the 
presence of Zn(II). This may simply be the result of a trigonal-bipyramidal (TBP) geometry for Co(II), Fe(II), and 
Mn(II) bound in the first site of MetAP's vs a tetrahedral (Td) or trigonal planar geometry if Zn(II) were bound 
instead (unpublished results). The proposal that Zn(II) prefers a Td geometry comes from the ligand field 
stabilization energies (LFSE's) for octahedral (Oh), Td, or trigonal planar geometries of Zn(II) and the observed X-
ray crystal structure of Zn(II)-loaded PfMetAP-II (unpublished results) and Zn(II) model complexes with mixed 
O/N ligands. For both Oh and Td geometries, the LFSE's are zero, suggesting that neither structure is favored. 
However, on the basis of X-ray crystallographic data, Zn(II) clearly favors a Td geometry (33). The reason for this 
is that the 4s and 4p orbitals are easily accessible as electron pair acceptors, providing an sp3-type center, while 
the 4d orbitals are higher in energy, making the formation of Oh or trigonal-bipyramidal (TBP) complexes less 
favorable. 
Another factor that might be involved in the catalytic process is the change in Lewis acidity between Co(II), 
Fe(II), or Mn(II) vs Zn(II). The effect of Lewis acidity on the reaction catalyzed by MetAP's can be gleaned from 
the kcat/Km values for Mn(II)-, Fe(II)-, and Co(II)-loaded forms of MetAP's determined at 30 °C. Toward the 
substrate MGMM, the kcat/Km values are 20800, 36900, and 30600 M-1 s-1 for Mn(II)-, Fe(II)-, and Co(II)-
loaded PfMetAP-II, respectively, and for Mn(II)-, Fe(II)-, and Co(II)-loaded EcMetAP-I the kcat/Km values are 3500, 
13700, and 12100 M-1 s-1, respectively. These observations are consistent with the fact that Mn(II) is a harder 
acid than either Fe(II) or Co(II); however, the kcat/Km values do not change markedly with regard to the metal ion 
in the active site. Therefore, these data suggest that Lewis acidity is not the major factor for catalytic turnover to 
occur. 
The proposal that a TBP geometry for the catalytic metal ion in the active site of MetAP's is required is also 
supported by the fact that when Cu(II) is substituted into EcMetAP-I, it resides in a square-based pyramidal (SP) 
geometry, and the resulting enzyme is inactive. Moreover, Ni(II) cannot activate MetAP's, but for Ni(II), an 
Oh geometry is significantly favored over Td or TBP geometries on the basis of LFSE's. These data, coupled with 
the fact that the vast majority of metalloproteases can be activated by every first row transition metal ion from 
Co(II) to Zn(II), suggest that the Lewis acidity of the metal ion bound in the active site of MetAP's is less 
important than the coordination geometry that the hydrolytic metal ion, M1, adopts. The geometrical 
importance of the catalytic metal ion in MetAP's is likely widely applicable to hydrolytic metalloenzymes with 
both mono- and dinuclear active sites. Thus, metal ion geometry is critical for the activated substrate and for the 
nucleophile to be positioned correctly for catalytic turnover to occur while Lewis acidity likely plays a secondary 
role to metal ion geometry. 
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acid; MAS, tripeptide Met-Ala-Ser; MGMM, tetrapeptide Met-Gly-Met-Met; EPR, electron paramagnetic 
resonance; EXAFS, extended X-ray absorption fine structure; XAS, X-ray absorption spectroscopy; ICP-
AES, inductively coupled plasma−atomic emission spectroscopy; NMR, nuclear magnetic resonance. 
 
